Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells

Lung Cancer

Volumn 70, Issue 3, 2010, Pages 263-270

  Saitoh, Yasunori ^a   Martínez Bruyn, Vicente Javier ^a   Uota, Shin ^a   Hasegawa, Atsuhiko ^a   Yamamoto, Naoki ^a,b   Imoto, Issei ^c   Inazawa, Johji ^c   Yamaoka, Shoji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

H1299; Mmp 9; NF B; NIK; NSCLC; RNA interference

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NK KAPPA B INDUCING KINASE; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; DNA BINDING; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRANSGENES;

EID: 78049364730     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.03.001     Document Type: Article

References (35)

1. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2:301-310.
2. Batra R.K., Guttridge D.C., Brenner D.A., Dubinett S.M., Baldwin A.S., Boucher R.C. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. Am J Respir Cell Mol Biol 1999, 2:238-245.
3. Kim J.Y., Lee S., Hwangbo B., Lee C.T., Kim Y.W., Han S.K., et al. NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis. Biochem Biophys Res Commun 2000, 273:140-146.
4. Tichelaar J.W., Zhang Y., leRiche J.C., Biddinger P.W., Lam S., Anderson M.W. Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies. BMC Cancer 2005, 5:155.
5. Tang X., Liu D., Shishodia S., Ozburn N., Behrens C., Lee J.J., et al. Nuclear factor-kB (NF-kB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 2006, 107:2637-2646.
6. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
7. Xiao G., Rabson A.B., Young W., Qing G., Qu Z. Alternative pathways of NF-κB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 2006, 17:281-293.
8. Xiao G., Harhaj E.W., Sun S.C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol Cell 2001, 7:401-409.
9. Rayet B., Gelinas C. Aberrant rel/nfκb genes and activity in human cancer. Oncogene 1999, 18:6938-6947.
10. Sun S.C., Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 2005, 24:5952-5964.
11. Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., Inazawa J. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res 2003, 9:4705-4713.
12. Izumi H., Inoue J., Yokoi S., Hosoda H., Shibata T., Sunamori M., et al. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 2005, 14:997-1007.
13. Mori N., Fujii M., Iwai K., Ikeda S., Yamasaki Y., Hata T., et al. Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. Blood 2000, 95:3915-3921.
14. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998, 93:1231-1240.
15. Saitoh Y., Yamamoto N., Dewan M.Z., Sugimoto H., Martinez Bruyn V.J., Iwasaki Y., et al. Overexpressed NF-κB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood 2008, 111:5118-5129.
16. Munoz E., Courtois G., Veschambre P., Jalinot P., Israel A. Tax induces nuclear translocation of NF-kappaB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol 1994, 68:8035-8044.
17. Yee J.K., Miyanohara A., Laporte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. PNAS 1994, 91:9564-9568.
18. Yamaoka S., Inoue H., Sakurai M., Sugiyama T., Hazama M., Yamada T., et al. Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J 1996, 15:873-887.
19. Liao G., Zhang M., Harhaj E.W., Sun S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem 2004, 279:26243-26250.
20. Qing G., Qu Z., Xiao G. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kB2 p100. J Biol Chem 2005, 280:40578-40582.
21. Annunziata C.M., Davis R.E., Demchenko Y., Bellamy W., Gabrea A., Zhan F., et al. Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007, 12:115-130.
22. Keats J.J., Fonseca R., Chesi M., Schop R., Baker A., Chng W.J., et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007, 12:131-144.
23. Zarnegar B., Yamazaki S., He J.Q., Cheng G. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci USA 2008, 105:3503-3508.
24. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52.
25. Farina A.R., Tacconelli A., Vacca A., Maroder M., Gulino A., Mackay A.R. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor κB elements. Cell Growth Differ 1999, 10:353-367.
26. Meylan E., Dooley A.L., Feldser D.M., Shen L., Turk E., Ouyang C., et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009, 462:104-107.
27. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-114.
28. Rundall B.K., Denlinger C.E., Jones D.R. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death. Surgery 2004, 136:416-425.
29. Waes C.V. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 2007, 13:1076-1082.
30. Jones D.R., Broad R.M., Madrid L.V., Baldwin A.S., Mayo M.W. Inhibition of NFkappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann Thorac Surg 2000, 70:930-937.
31. Kawauchi K., Araki K., Tobiume K., Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol 2008, 10:611-618.
32. Kawauchi K., Araki K., Tobiume K., Tanaka N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc Natl Acad Sci USA 2009, 106:3431-3436.
33. Huang W.C., Ju T.K., Hung M.C., Chen C.C. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 2007, 26:75-87.
34. Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., et al. Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK deficient mice. Science 2001, 291:2162-2165.
35. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., Miyamoto S. Sequential modification of NEMO/IKKα by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 2003, 115:565-576.